Bellwether Bio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $8.7M

  • Investors
  • 1

Bellwether Bio General Information

Description

Developer of novel cell-free DNA-based diagnostic technologies designed to cure cancer treatment. The company's technologies offer to improve the accuracy for cancer and other conditions and commercializing liquid biopsy technology that can test the DNA of a patient's cancer without performing a traditional, invasive biopsy, enabling cancer patients to start the treatment more quickly, resulting in a higher likelihood of more successful treatment.

Contact Information

Website
www.bellwetherbio.com
Formerly Known As
Haverhill Genetics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 600 1st Avenue
  • Seattle, WA 98104
  • United States
+1 (206)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Guardant Health
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 600 1st Avenue
  • Seattle, WA 98104
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bellwether Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Apr-2019 $8.7M Completed Product Development
3. Early Stage VC 01-May-2018 Completed Product Development
2. Seed Round 07-Feb-2017 $2.75M $2.75M Completed Product Development
1. University Spin-Out 01-Jan-2016 Completed Startup
To view Bellwether Bio’s complete valuation and funding history, request access »

Bellwether Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel cell-free DNA-based diagnostic technologies designed to cure cancer treatment. The company's technolo
Diagnostic Equipment
Seattle, WA

Cambridge, United Kingdom
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bellwether Bio Competitors (48)

One of Bellwether Bio’s 48 competitors is ROCA Test, a Formerly VC-backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ROCA Test Formerly VC-backed Cambridge, United Kingdom
Genefirst Venture Capital-Backed Abingdon, United Kingdom
Foundation Medicine Formerly VC-backed Boston, MA
QuantuMDx Venture Capital-Backed Newcastle Upon Tyne, United Kingdom
DNAe Formerly VC-backed London, United Kingdom
You’re viewing 5 of 48 competitors. Get the full list »

Bellwether Bio Patents

  • 30

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Bellwether Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200199685-A1 Determination of a physiological condition with nucleic acid fragment endpoints Inactive 17-Dec-2018
US-20230287516-A1 Determination of a physiological condition with nucleic acid fragment endpoints Pending 17-Dec-2018
EP-3635133-A1 Determination of cancer type in a subject by probabilistic modeling of circulating nucleic acid fragment endpoints Active 09-Jun-2017
EP-3635133-A4 Determination of cancer type in a subject by probabilistic modeling of circulating nucleic acid fragment endpoints Active 09-Jun-2017
EP-3635133-B1 Determination of cancer type in a subject by probabilistic modeling of circulating nucleic acid fragment endpoints Active 09-Jun-2017 G16B40/00
To view Bellwether Bio’s complete patent history, request access »

Bellwether Bio Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Planetary Technologies Venture Capital Minority
The W Fund Venture Capital Minority
WRF Capital Corporate Venture Capital Minority
To view Bellwether Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Bellwether Bio FAQs

  • When was Bellwether Bio founded?

    Bellwether Bio was founded in 2016.

  • Where is Bellwether Bio headquartered?

    Bellwether Bio is headquartered in Seattle, WA.

  • What industry is Bellwether Bio in?

    Bellwether Bio’s primary industry is Diagnostic Equipment.

  • Is Bellwether Bio a private or public company?

    Bellwether Bio is a Private company.

  • What is the current valuation of Bellwether Bio?

    The current valuation of Bellwether Bio is .

  • What is Bellwether Bio’s current revenue?

    The current revenue for Bellwether Bio is .

  • How much funding has Bellwether Bio raised over time?

    Bellwether Bio has raised $2.94M.

  • Who are Bellwether Bio’s investors?

    Planetary Technologies, The W Fund, and WRF Capital have invested in Bellwether Bio.

  • Who are Bellwether Bio’s competitors?

    ROCA Test, Genefirst, Foundation Medicine, QuantuMDx, and DNAe are some of the 48 competitors of Bellwether Bio.

  • When was Bellwether Bio acquired?

    Bellwether Bio was acquired on 24-Apr-2019.

  • Who acquired Bellwether Bio?

    Bellwether Bio was acquired by Guardant Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process